Are Hospital Acquisitions with COPA Authorization Exempt from HSR Pre-Merger Notification?
By: Marc Schildkraut (Antitrust Advocate)
The Federal Trade Commission (FTC) has suffered several recent setbacks concerning its regulatory authority. The U.S. Supreme Court has ruled that the FTC lacks authority to obtain monetary redress relief for consumers in federal court, so it would have to adjudicate the conduct in an FTC administrative proceeding. However, the Court also recently ruled that respondents need not wait until the FTC completes its administrative action to appeal. Meanwhile, a new dispute has emerged, raising questions about whether hospital acquisitions with Certificate of Public Advantage (COPA) authorization are exempt from Hart-Scott-Rodino Act pre-merger notification…
Featured News
Subscribers Defend $4.7 Billion Antitrust Verdict Against NFL in Court Filings
Jul 19, 2024 by
CPI
Von der Leyen Calls for Competition Policy to Boost EU Companies’ Growth
Jul 19, 2024 by
CPI
Vermont AG Sues Pharmacy Benefit Managers Over Drug Prices
Jul 18, 2024 by
CPI
Australians Face Increased Stamp Prices Following ACCC Approval
Jul 18, 2024 by
CPI
Live Nation Seeks Dismissal of DOJ Antitrust Allegations
Jul 18, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Private Equity Roll-Up Schemes
Jun 28, 2024 by
CPI
The FTC’s Focus on Private Equity is Warranted
Jun 28, 2024 by
CPI
Unraveling the Roll-Up: Private Equity’s Misunderstood Investment Strategy
Jun 28, 2024 by
CPI
Antitrust Focus on Private Equity Funds and Serial Acquisitions
Jun 28, 2024 by
CPI
Private Equity Roll-Ups Amidst Heightened Antitrust Enforcement
Jun 28, 2024 by
CPI